Stockreport

Here's Why We're Not Too Worried About Cullinan Oncology's (NASDAQ:CGEM) Cash Burn Situation [Yahoo! Finance]

Cullinan Therapeutics, Inc.  (CGEM) 
PDF lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But the harsh reality is that very many loss makin [Read more]